Drug Shortage Report for ZOLEDRONIC ACID FOR INJECTION

Last updated on 2023-10-03 History
Report ID 117593
Drug Identification Number 02407639
Brand name ZOLEDRONIC ACID FOR INJECTION
Common or Proper name ZOLEDRONIC ACID FOR INJECTION 0.8MG/ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ml
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-10
Estimated end date
Actual end date 2020-06-30
Shortage status Resolved
Updated date 2023-10-03
Company comments Item is to be discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-06-11 English Compare
v2 2020-06-11 English Compare
v3 2020-06-11 French Compare
v4 2021-05-06 English Compare
v5 2021-05-06 French Compare
v6 2023-10-03 English Compare

Showing 1 to 6 of 6